Yue Liu
- Cancer Research top 2%
- Cancer, Lipids, and Metabolism 16
- Cancer-related molecular mechanisms research 16
- MicroRNA in disease regulation 12
- Molecular Biology top 5%
- RNA modifications and cancer 25
- RNA Research and Splicing 10
- Immunology top 5%
- Immunotherapy and Immune Responses 11
- Oncology top 5%
-
- Ferroptosis and cancer prognosis 25
- Lung Cancer Treatments and Mutations 11
- Co-authors
- Yufeng ShiJin ZhangLei‐Lei WuShi-Ping LuLixue YangLiang YangMou‐Tuan HuangYanjin Wang
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Journal of Biological Chemistry (1 paper)Angewandte Chemie International Edition (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Yue Liu
207 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Cancer Research 984
- Molecular Biology 2.2k
- Immunology 644
- Oncology 715
- Pulmonary and Respiratory Medicine 800
Countries citing papers authored by Yue Liu
This map shows the geographic impact of Yue Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yue Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yue Liu more than expected).
Fields of papers citing papers by Yue Liu
This network shows the impact of papers produced by Yue Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yue Liu. The network helps show where Yue Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yue Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 8 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 10 | |
| 9 | 2023 | 8 | |
| 10 | 2023 | 0 | |
| 11 | 2023 | 32 | |
| 12 | 2023 | 12 | |
| 13 | 2023 | 28 | |
| 14 | 2023 | 7 | |
| 15 | 2023 | 9 | |
| 16 | 2022 | 93 | |
| 17 | Stem Cell Factor SOX2 Confers Ferroptosis Resistance in Lung Cancer via Upregulation of SLC7A11breakdown → | 2021 | 187 |
| 18 | 2021 | 8 | |
| 19 | 2021 | 13 | |
| 20 | 2008 | 256 |
About Yue Liu
Yue Liu is a scholar working on Research and Theory, Cancer Research and Oncology, having authored 227 papers that have together received 4.3k indexed citations. Recurring topics across this work include RNA modifications and cancer (25 papers), Ferroptosis and cancer prognosis (25 papers), Cancer, Lipids, and Metabolism (16 papers), Cancer-related molecular mechanisms research (16 papers), MicroRNA in disease regulation (12 papers), Lung Cancer Treatments and Mutations (11 papers), Immunotherapy and Immune Responses (11 papers) and RNA Research and Splicing (10 papers). The work is most often cited by research in Cancer Research (984 citations), Molecular Biology (2.2k citations) and Immunology (644 citations). Yue Liu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Yufeng Shi, Jin Zhang, Lei‐Lei Wu, Shi-Ping Lu, Lixue Yang, Liang Yang, Mou‐Tuan Huang, Yanjin Wang, Yi Wang and Ah‐Ng Tony Kong. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.